Everolimus-eluting stents in interventional cardiology
نویسندگان
چکیده
منابع مشابه
Everolimus-eluting stents in interventional cardiology
Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis. First-generation drug-eluting stents successfully countered the restenosis rate, but were hampered by concerns about their long-term safety. Second generation drug-eluting stents have combined the low restenosis rate of the first generation with improved long-term safety. We review the evol...
متن کاملInterventional Cardiology Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents 1-Year Outcomes from the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial (RESET)
Background—Several recent randomized trials comparing everolimus-eluting stent (EES) and sirolimus-eluting stent (SES) reported similar outcomes. However, only 1 trial was powered for a clinical end point, and no trial was powered for evaluating target-lesion revascularization. Methods and Results—Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial is a prospective ...
متن کاملInterventional Cardiology Sirolimus-eluting coronary stents in small vessels
Sirolimus-eluting coronary stents in small vessels Bernhard Meier, MD, FACC, FESC, Eduardo Sousa, MD, Giulio Guagliumi, MD, Frank Van den Branden, MD, Ehud Grenadier, MD, Stephan Windecker, MD, Hans te Riele, MD, Vasilis Voudris, MD, Hélène Eltchaninoff, MD, Bo Lindvall, MD, David Snead, PhD, and Aly Talen, RN, for the SVELTE Study Group Bern, Switzerland; Sao Paolo, Brazil; Bergamo, Italy; Ant...
متن کاملDrug Eluting Stents; A new era in Interventional Cardiology
INTRODUCTION Over the last decade or so, no other subspecialty of medicine has seen such technological innovations, as interventional cardiology. These advances have revolutionized the management of coronary artery disease. From statin drugs to oral platelets inhibitors like clopidogrel and ticlopidine, intravenous platelet glycoprotein IIb/IIIa receptor blockers like Abciximab (Reo-Pro), Eptif...
متن کاملEverolimus-eluting coronary stents
Bare metal stents enabled a reduction in the risk of early procedural complications and restenosis in comparison with balloon angioplasty alone, but introduced a new and device-specific iatrogenic condition, ie, in-stent restenosis due to increased neointimal hyperplasia. Sirolimus- and paclitaxel-eluting stents reduce restenosis and the need for new revascularizations in comparison with bare m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vascular Health and Risk Management
سال: 2012
ISSN: 1178-2048
DOI: 10.2147/vhrm.s23388